Back Source: > 28 November 2009 (E-Business) Rigel Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile--Aarkstore Enterprise New report "Rigel Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" available through Aarkstore.com  Rigel Pharmaceuticals, Inc. (Rigel) is a clinical-stage drug development company. The company is engaged in the discovery and development of novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. The company develops its products based on signaling pathways and related targets that are critical to disease mechanisms. The company principally operates in the U.S. with its headquarters in South San Francisco. Rigel Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals. Scope - Provides key company information for business intelligence needs - Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships. - Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement. For more information please visit : http://www.aarkstore.com/reports/Rigel-Pharmaceuticals-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-20000.html  Visit